Royal Bank Of Canada Harrow Health, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Harrow Health, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 6,306 shares of HROW stock, worth $206,206. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,306

Previous 3,950 59.65%

Holding current value

$206,206

Previous $82,000 245.12%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$20.85 - $46.47 $49,122 - $109,483	2,356 Added 59.65%	6,306 $283,000
Q2 2024 Aug 14, 2024	BUY	$10.0 - $21.64 $22,750 - $49,231	2,275 Added 135.82%	3,950 $82,000
Q1 2024 Nov 05, 2024	SELL	$9.3 - $13.23 $21,157 - $30,098	-2,275 Reduced 57.59%	1,675 $22,000
Q1 2024 May 15, 2024	SELL	$9.3 - $13.23 $75,860 - $107,917	-8,157 Reduced 82.96%	1,675 $22,000
Q4 2023 Feb 14, 2024	BUY	$8.1 - $16.36 $42,873 - $86,593	5,293 Added 116.61%	9,832 $110,000
Q3 2023 Nov 14, 2023	SELL	$14.03 - $22.08 $41,402 - $65,158	-2,951 Reduced 39.4%	4,539 $65,000
Q2 2023 Aug 14, 2023	BUY	$17.37 - $28.08 $82,021 - $132,593	4,722 Added 170.59%	7,490 $142,000
Q1 2023 May 15, 2023	SELL	$13.84 - $21.46 $15,016 - $23,284	-1,085 Reduced 28.16%	2,768 $58,000
Q4 2022 Feb 14, 2023	BUY	$10.28 - $14.78 $19,532 - $28,082	1,900 Added 97.29%	3,853 $56,000
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $657 - $2,488	100 Added 5.4%	1,953 $24,000
Q2 2022 Aug 15, 2022	SELL	$5.75 - $7.74 $3,398 - $4,574	-591 Reduced 24.18%	1,853 $13,000
Q1 2022 May 16, 2022	BUY	$6.77 - $8.66 $4,001 - $5,118	591 Added 31.89%	2,444 $17,000
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $150,671 - $212,712	-17,726 Reduced 90.54%	1,853 $16,000
Q3 2021 Nov 15, 2021	SELL	$6.99 - $10.6 $174,966 - $265,328	-25,031 Reduced 56.11%	19,579 $178,000
Q2 2021 Aug 16, 2021	BUY	$6.68 - $11.07 $297,994 - $493,832	44,610 New	44,610 $415,000

Others Institutions Holding HROW

# of Institutions

179

Shares Held

21.3M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $885M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Harrow Health, Inc. Transaction History